FDA Approves Regeneron & EUSA Drugs
Regeneron Pharmaceuticals and EUSA Pharma have announced that US regulators have approved their blindness drug and leukaemia therapy, respectively. The US FDA (Food and Drug Administration) has given the okay to Regeneron’s Eylea, also known as VEGF Trap-Eye, for the treatment of patients with wet age-related Macular Degeneration at a recommended dose of 2 milligrams